Vanguard Group
TVRD

Vanguard Group’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$9.29M Buy
398,410
+230,309
+137% +$5.37M ﹤0.01% 2943
2025
Q1
$852K Hold
168,101
﹤0.01% 3761
2024
Q4
$1.03M Sell
168,101
-2,080,810
-93% -$12.7M ﹤0.01% 3756
2024
Q3
$693K Sell
2,248,911
-1,423
-0.1% -$438 ﹤0.01% 3885
2024
Q2
$581K Sell
2,250,334
-230,924
-9% -$59.6K ﹤0.01% 3949
2024
Q1
$2.26M Sell
2,481,258
-149,809
-6% -$136K ﹤0.01% 3556
2023
Q4
$1.95M Buy
2,631,067
+32,618
+1% +$24.2K ﹤0.01% 3617
2023
Q3
$4.37M Buy
2,598,449
+4,471
+0.2% +$7.51K ﹤0.01% 3309
2023
Q2
$7.34M Sell
2,593,978
-528,848
-17% -$1.5M ﹤0.01% 3122
2023
Q1
$15.3M Buy
3,122,826
+21,102
+0.7% +$104K ﹤0.01% 2718
2022
Q4
$33.3M Sell
3,101,724
-206,127
-6% -$2.21M ﹤0.01% 2377
2022
Q3
$31M Buy
3,307,851
+40,197
+1% +$376K ﹤0.01% 2419
2022
Q2
$29.8M Buy
3,267,654
+23,277
+0.7% +$213K ﹤0.01% 2441
2022
Q1
$39.4M Buy
3,244,377
+211,615
+7% +$2.57M ﹤0.01% 2419
2021
Q4
$36.9M Buy
3,032,762
+21,882
+0.7% +$267K ﹤0.01% 2518
2021
Q3
$46.5M Buy
3,010,880
+265,783
+10% +$4.11M ﹤0.01% 2403
2021
Q2
$39.2M Buy
2,745,097
+491,850
+22% +$7.02M ﹤0.01% 2495
2021
Q1
$48.9M Sell
2,253,247
-5,516
-0.2% -$120K ﹤0.01% 2332
2020
Q4
$34.2M Buy
2,258,763
+18,964
+0.8% +$287K ﹤0.01% 2386
2020
Q3
$28.5M Sell
2,239,799
-16,669
-0.7% -$212K ﹤0.01% 2291
2020
Q2
$38.6M Sell
2,256,468
-20,229
-0.9% -$346K ﹤0.01% 2135
2020
Q1
$30.1M Buy
2,276,697
+105,152
+5% +$1.39M ﹤0.01% 2097
2019
Q4
$35M Sell
2,171,545
-1,141
-0.1% -$18.4K ﹤0.01% 2272
2019
Q3
$39.7M Buy
2,172,686
+393,234
+22% +$7.19M ﹤0.01% 2184
2019
Q2
$38.3M Buy
1,779,452
+13,417
+0.8% +$288K ﹤0.01% 2237
2019
Q1
$34.6M Buy
1,766,035
+121,225
+7% +$2.38M ﹤0.01% 2268
2018
Q4
$21.4M Buy
1,644,810
+93,466
+6% +$1.22M ﹤0.01% 2412
2018
Q3
$37.2M Buy
1,551,344
+305,020
+24% +$7.31M ﹤0.01% 2297
2018
Q2
$23.9M Buy
1,246,324
+15,408
+1% +$295K ﹤0.01% 2492
2018
Q1
$15.2M Buy
1,230,916
+13,555
+1% +$168K ﹤0.01% 2609
2017
Q4
$14.9M Buy
1,217,361
+35,144
+3% +$430K ﹤0.01% 2630
2017
Q3
$16.2M Buy
1,182,217
+74,343
+7% +$1.02M ﹤0.01% 2577
2017
Q2
$17.1M Buy
1,107,874
+164,247
+17% +$2.53M ﹤0.01% 2528
2017
Q1
$17.4M Buy
943,627
+156,958
+20% +$2.89M ﹤0.01% 2497
2016
Q4
$7.31M Buy
786,669
+63,220
+9% +$587K ﹤0.01% 2882
2016
Q3
$6.04M Buy
723,449
+52,984
+8% +$442K ﹤0.01% 2911
2016
Q2
$3.23M Sell
670,465
-16,974
-2% -$81.6K ﹤0.01% 3184
2016
Q1
$4.28M Buy
687,439
+30,409
+5% +$189K ﹤0.01% 3051
2015
Q4
$11.1M Buy
657,030
+119,363
+22% +$2.01M ﹤0.01% 2584
2015
Q3
$7.68M Buy
537,667
+252,260
+88% +$3.61M ﹤0.01% 2742
2015
Q2
$3.47M Buy
285,407
+53,629
+23% +$652K ﹤0.01% 3182
2015
Q1
$2.33M Buy
231,778
+56,676
+32% +$570K ﹤0.01% 3337
2014
Q4
$1.75M Sell
175,102
-197
-0.1% -$1.96K ﹤0.01% 3335
2014
Q3
$1.47M Sell
175,299
-66,568
-28% -$559K ﹤0.01% 3381
2014
Q2
$4.12M Buy
241,867
+145,831
+152% +$2.48M ﹤0.01% 2943
2014
Q1
$1.79M Buy
+96,036
New +$1.79M ﹤0.01% 3272